Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2009
06/16/2009US7547706 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use
06/16/2009US7547705 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes
06/16/2009US7547698 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
06/16/2009CA2264750C Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
06/11/2009WO2009073777A1 Gamma secretase modulators
06/11/2009WO2009071707A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases
06/11/2009WO2009071706A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases
06/11/2009WO2009071705A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases
06/11/2009WO2009071638A2 Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives
06/11/2009WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators
06/11/2009WO2009071477A1 Isoxazolo-pyridazine derivatives
06/11/2009WO2009071476A1 Isoxazolo-pyridine derivatives
06/11/2009WO2009016516A3 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
06/11/2009WO2006119504A3 Fused heterocyclic compounds, and compositions and uses thereof
06/11/2009US20090149526 Tetracyclic Indole Derivatives as Antiviral Agents
06/11/2009US20090149525 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
06/11/2009US20090149483 Bicyclic pyrrole derivatives
06/11/2009US20090149468 Substituted heterocyclic compounds and methods of use
06/11/2009US20090149467 Tyrosine Kinase Inhibitors
06/11/2009US20090149459 P38 inhibitors and methods of use thereof
06/11/2009US20090149458 PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS
06/11/2009US20090149450 Substituted imidazoheterocycles
06/11/2009US20090149449 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149444 Benzylamine analogues
06/11/2009US20090149436 Caspase inhibitor
06/11/2009US20090146555 Heterocyclic compound and organic light emitting device comprising the same
06/11/2009CA2707821A1 Isoxazolo-pyridazine derivatives
06/11/2009CA2707712A1 Gamma secretase modulators
06/11/2009CA2707648A1 Isoxazolo-pyridine derivatives
06/11/2009CA2707421A1 Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives
06/10/2009EP2066674A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents
06/10/2009EP2066673A2 Tricyclic compounds and its use as tyrosine kinase modulators
06/10/2009EP2066672A1 An improved process for the preparation of temozolomide and analogs
06/10/2009EP2066671A1 Transition state structure of human 5'-methylthioadenosine phosphorylase
06/10/2009EP2066670A2 Integrase inhibitors
06/10/2009EP2066666A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders
06/10/2009EP2066657A1 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands
06/10/2009EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
06/10/2009EP2066316A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
06/10/2009EP1836205B1 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS
06/10/2009EP1718649B1 Imidazo 1,2-c pyrimidinylacetic acid derivatives
06/10/2009EP1711499B1 Fused pyrrolocarbazoles and methods for the preparation thereof
06/10/2009EP1601673B1 Fused heterocycles and uses thereof
06/10/2009CN101454327A Azolopyrimidines as inhibitors of cannabinoid 1 activity
06/10/2009CN101454326A Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
06/10/2009CN100497341C Porphyrin derivative and its preparation process and use
06/10/2009CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists
06/10/2009CN100497339C Pyrimido compounds
06/09/2009US7544796 Colorant compounds
06/09/2009US7544705 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
06/09/2009US7544698 Indoles and benzoimidazoles as modulators of the histamine H4 receptor
06/09/2009US7544685 2,3-dihydroindole compounds
06/09/2009US7544680 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
06/09/2009US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
06/09/2009US7544672 Heat Shock Protein 90 (HSP90) inhibiting agents; 3-[2-Amino-4-chloro-7-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-prop-2-yn-1-ol; inflammatory, autoimmune, metabolic disorders, stroke, ischemia, cardiac, neurological disorders, fibrogenetic disorders, cancer
06/09/2009US7544312 Charge transport compositions and electronic devices made with such compositions
06/04/2009WO2009070644A1 Prolyl hydroxylase inhibitors
06/04/2009WO2009070584A1 Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
06/04/2009WO2009070567A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
06/04/2009WO2009070524A1 Pyrrolo[3,2-d]pyrimidine compounds and their use as pi3 kinase and mtor kinase inhibitors
06/04/2009WO2009070485A1 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES
06/04/2009WO2009070314A2 Crystalline form of sitagliptin
06/04/2009WO2009069806A1 Process for production of pyrrole compound
06/04/2009WO2009069736A1 Nitrogenated compound
06/04/2009WO2009069717A1 Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device
06/04/2009WO2009068955A2 Polymorphs of a c-met/hgfr inhibitor
06/04/2009WO2009068617A1 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a modulators for the teatment of cns disorders
06/04/2009WO2009068595A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/04/2009WO2009068512A1 2 -amino-pyrimidine derivatives as histamine h4 antagonists
06/04/2009WO2009068320A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
06/04/2009WO2009051399A3 Novel compounds of reverse turn mimetics and the use thereof (1)
06/04/2009WO2009051398A3 Novel compounds of reverse turn mimetics and the use thereof (2)
06/04/2009WO2009051397A3 Novel compounds of reverse turn mimetics and the use thereof (3)
06/04/2009WO2009042711A4 Polo-like kinase inhibitors
06/04/2009WO2009040817A3 Salarins and tulearins, compositions and uses thereof
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/04/2009US20090143580 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AS METABOTROPIC GLUTAMATE ANTAGONISTS
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143574 Carbapenem Compound
06/04/2009US20090143432 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
06/04/2009US20090143422 P38 inhibitors and methods of use thereof
06/04/2009US20090143399 Protein Kinase Inhibitors
06/04/2009US20090143391 Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10
06/04/2009US20090143389 Heterocyclic inhibitors of mek and methods of use thereof
06/04/2009US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents
06/04/2009US20090143371 Isoxazole-pyridine derivatives
06/04/2009US20090143367 8-chloro-3,4-dimethyl-1-(2- methylphenyl)imidazo[1,5- a]quinoxaline; inhibitors of phosphodiesterase 10; for treatment of central nervous system disorders (cognitive deficits, social phobia, reduced vigilance, obesity and psychosis)
06/04/2009US20090143356 Polycylclic Carbamoylpyridone Derivative Having HIV Integrase Inhibitory Acitvity
06/04/2009US20090143354 P2X7 Receptor Antagonists and Their Use
06/04/2009US20090142797 Blood diluent and method of use thereof
06/04/2009CA2707014A1 Method for preparing tetrapyrrole compounds and tetrapyrrole compounds
06/04/2009CA2706986A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
06/04/2009CA2706974A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/04/2009CA2706946A1 2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
06/04/2009CA2706866A1 Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
06/04/2009CA2706430A1 Polymorphs of a c-met/hgfr inhibitor
06/04/2009CA2706018A1 1, 5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders
06/04/2009CA2705583A1 Derivatives of 6,7-dihydro-5h-imidazo[1,2-.alpha.]imidazole-3-carboxylic acid amides
06/03/2009EP2065368A1 Inhibitors of IAP
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 573